期刊文献+

2型糖尿病合并高血压的研究进展 被引量:11

下载PDF
导出
摘要 最近几十年,全球糖尿病患者人数以惊人的速度迅速增长,糖尿病特别是2型糖尿病目前已成为严重影响人类身心健康的主要公共卫生问题。随着我国经济的快速发展,糖尿病的发病率也飞速增长。根据国际糖尿病组织报告,2003年中国约有糖尿病患者2260万,目前中国已成为仅次于印度的世界第二糖尿病大国,以目前的增长趋势,预计到2025年,中国的糖尿病患者将达到5000万。更为危险的是,有证据表明,
出处 《实用心脑肺血管病杂志》 2011年第5期701-702,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献10

  • 1潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:396
  • 2邹飒枫,乔晶,唐伟.医保人员糖尿病和糖尿病合并高血压及并发症现状分析[J].中国预防医学杂志,2010,11(5):495-497. 被引量:4
  • 3UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes: UKPDS 38 [ J ]. BMI, 1998, 317:703-713.
  • 4曾正陪.应当重视内分泌性高血压的诊治[J].中华医学信息导报,2003,18(16):4-5. 被引量:1
  • 5Nishimoto Y, Miyazaki Y, Toki Y, et al. Long - term result of the ku- mamoto study on optimal diabetes control in type 2 diabetes of coronary arteries: elective pereutaneous transluminal coronary angioplasty in pa- tients with effort angina [J]. J AM Coil Cardiol, 1998, 32:1624 - 1629.
  • 6Hypertension in Dibetes IV. Therapeutic requirements to maintain tight blood pressure control [J]. Dibetologia, 1996, 39:1554 - 1561.
  • 7Hansson L, Zanchetti A, Carruthers SG, et al. Effects of inter sire blood pressure lowing and low - dose asprin in patietnts with hyperten- sion: principal results of the Hypertension Optimal Treatment (HOT) randomized trial [J]. HOT Study Group, Lancent, 1998, 351: 1755 - 1762.
  • 8Hansson LH, Lindhalm LH, Niskanen, et al. Effect of angiotensin converting enzyme inhibition compared with conventional therapy on car- diovascular morbidity and mortality in hypertension the Captopril Project randomised trial [J]. Lancet, 1999, 53:611-616.
  • 9叶任高.内科学[M]5版.北京:人民卫生出版社,2001.258.
  • 10齐国先,李学渊.高血压合并糖尿病的降压策略[J].中国实用内科杂志,2009,29(9):795-797. 被引量:21

二级参考文献14

  • 1胡玲,江芳芳,陆君,伍英,梅承艳,孙掌花,陶武斌.强化降糖和降压治疗2型糖尿病大血管病变的前瞻性研究[J].中国实用内科杂志,2005,25(10):916-917. 被引量:6
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:35-38.
  • 3UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complication in type 2 diabetes UKPDS 38 [ J ]. BMI, 1998,317:703 - 720.
  • 4Khan NA, Hemmelgarn B, Herman R J, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension:Part 2-therapy [ J ]. Can J Cardiol,2009,25 (5) :287 -298.
  • 5Mansia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension ( ESH ) and of the European Society of Cardiology ( ESC ) [J]. Blood Press,2007,16 ( 3 ) : 135 - 232.
  • 6Chobanian AV, Bakris GL, Black HR, et al. Committee on prevention, detection, evaluation, and treatment of high blood pressure : the JNC7 report[J]. JAMA,2003,289(19) :2560-2572.
  • 7Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an updaice [J]. Hypertension, 1995, 26 (5): 869-879.
  • 8Cerbone AM, Macarone Palmieri N, Saldalamacchia G, et al. Diabetes, vascular complications and antiplatelet therapy: open problems [J].Acta Diabetol, 2008, 36 (12):830-839.
  • 9O'Sullivan EP, Bhargava A, O'Callaghan M, et al. Awareness of diabetes complications in an Irish population [J].Ir J Med Sci, 2009, 28 (4):215-231.
  • 10Rachmani R, Levi Z, Slavachevski I, et al. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus-a randomized prospective study [J]. Diabet Med, 2002, 19 (5): 385-392.

共引文献736

同被引文献100

引证文献11

二级引证文献158

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部